KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Goodwill & Intangibles: 2009-2012

Historic Goodwill & Intangibles for Alnylam Pharmaceuticals (ALNY) over the last 4 years, with Sep 2012 value amounting to $145,000.

  • Alnylam Pharmaceuticals' Goodwill & Intangibles fell 54.40% to $145,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $145,000, marking a year-over-year decrease of 54.40%. This contributed to the annual value of $275,000 for FY2011, which is 38.62% down from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Goodwill & Intangibles of $145,000 as of Q3 2012, which was down 22.87% from $188,000 recorded in Q2 2012.
  • In the past 5 years, Alnylam Pharmaceuticals' Goodwill & Intangibles ranged from a high of $982,108 in Q1 2009 and a low of $145,000 during Q3 2012.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $361,000 (2011), whereas its average is $381,578.
  • Data for Alnylam Pharmaceuticals' Goodwill & Intangibles shows a maximum YoY plummeted of 54.40% (in 2012) over the last 5 years.
  • Alnylam Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $918,529 in 2009, then slumped by 51.23% to $448,000 in 2010, then tumbled by 38.62% to $275,000 in 2011, then plummeted by 54.40% to $145,000 in 2012.
  • Its last three reported values are $145,000 in Q3 2012, $188,000 for Q2 2012, and $231,000 during Q1 2012.